" /> Labeling Supplement - CISMeF





Preferred Label : Labeling Supplement;

Alternative definition : FDA: For NDAs, ANDAs, and BLAs, this represents a request to modify an existing label that do not rise to the level of an efficacy supplement for purposes such as adding additional safety information, clarification, etc. Labeling supplements may only be submitted once the original-application has been approved/licensed.;

Details


You can consult :


Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.